Avalo Therapeutics Announces Key Developments and Financial Overview for Q1 2025
May 12, 2025 - 14:37
Mike Heffernan has been appointed as the new Chairman of the Board at Avalo Therapeutics, marking a significant leadership change for the company. In addition to this appointment, the company is anticipating the release of topline data from its Phase 2 LOTUS trial for AVTX-009, a treatment aimed at addressing hidradenitis suppurativa, with results expected in 2026.
As of March 31, 2025, Avalo reported a robust cash position of approximately $125 million, which is projected to provide sufficient financial runway into 2027. This funding will allow the company to continue its focus on developing innovative therapies for immune dysregulation, with the potential to extend operations into 2028 if necessary.
These updates reflect Avalo's commitment to advancing its clinical programs and enhancing shareholder value as it navigates the complexities of the biotechnology landscape. The leadership transition and solid financial standing position the company for future growth and success in the coming years.
MORE NEWS
August 12, 2025 - 11:47
Resolution of Hall and Oates Business Dispute Through ArbitrationThe recent business dispute between music legends Daryl Hall and John Oates has reached a resolution through arbitration. The conflict initially came to light in November 2023 when Hall filed a...
August 11, 2025 - 19:48
Rising Star: Anna Jacobs Shines in BusinessGrowing up in an entrepreneurial family, Anna Jacobs always envisioned herself as a business owner. Her mother runs a family enterprise that her grandfather established nearly 70 years ago,...
August 11, 2025 - 03:17
Third Bomb Threat Investigated at Nantucket BusinessNantucket police have responded for the third time in just four days to a report of an improvised explosive device at a Main Street business. This alarming series of incidents has raised concerns...
August 10, 2025 - 19:50
The Impact of AI on the Search Industry: Separating Fact from FictionConcerns over a potential plunge in web traffic due to artificial intelligence — and its impact on many businesses — may have been overblown. As AI continues to evolve, its integration into...